Brit living in US. Work in #Genomics, #proteomics, #metabolomics, #biotechnology #healthcare. Supports #stokecity. All views my own

Newburyport, MA
Joined December 2010
James Forrest-Hay with the equalizer!! #GoHill | #NECMSOC
3
8
168
The power of multi-plexed ultra-sensitive biomarker detection to understand neurodegenerative disease! Congrats @NicholasAshton @AlamarBio
Fluid biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno-Sandwich Assay @AlamarBio @andrealessa alz-journals.onlinelibrary.w…
1
1
151
Our friends and partners at @AlamarBio explain how their highly sensitive and multiplexed profiling technology can support and boost the field’s aging biomarker R&D programs.
1
5
444
This meeting is going to be so interesting. @AlamarBio will be showcasing data showing how ultra-sensitive protein biomarkers can be used to calculate biological age.
🌟 2024 Biomarkers of Aging Conference Speaker Highlight 🌟 Dr. Ma is the CTO of Alamar Biosciences (@AlamarBio), a life science tools company developing next-generation proteomic technologies for liquid biopsies. His work focuses on innovation in biomarker technologies such as RNAscope and NULISA, and he also has extensive experience in applying novel technologies to biomarker discovery and diagnostic assay development. Join us on November 1-2 at Harvard Medical School for the 2024 Biomarkers of Aging Conference, where Dr. Ma and other pioneers in longevity will present cutting-edge research on reliable biomarkers of aging for longevity interventions. Ticket sales end in just a few days on October 21st, so be sure to secure your tickets soon! buff.ly/3JRDZjn
2
134
🌟 2024 Biomarkers of Aging Conference Speaker Highlight 🌟 Dr. Ma is the CTO of Alamar Biosciences (@AlamarBio), a life science tools company developing next-generation proteomic technologies for liquid biopsies. His work focuses on innovation in biomarker technologies such as RNAscope and NULISA, and he also has extensive experience in applying novel technologies to biomarker discovery and diagnostic assay development. Join us on November 1-2 at Harvard Medical School for the 2024 Biomarkers of Aging Conference, where Dr. Ma and other pioneers in longevity will present cutting-edge research on reliable biomarkers of aging for longevity interventions. Ticket sales end in just a few days on October 21st, so be sure to secure your tickets soon! buff.ly/3JRDZjn
1
1
2
395
🚨 Available as a preprint – The @alzassociation #pTau round robin study 🚨 📣 33 different ways to measure #blood #pTau 📣 Mass Spec, semi & fully-auto immunoassays 📣 #pTau217 consistently best 📣 Corr. between assays = optimism for standardisation medrxiv.org/content/10.1101/…
2
22
4
63
13,558
NULISA—A New Proteomic Method to Revamp Biomarker Analysis | ALZFORUM ⁦@AlamarBio⁩ - the blood biomarker landscape is changing with NULISA! alzforum.org/news/conference…
90
The collection of #blood #biomarkers studies using NULISA as presented at day two of #AAIC2024 is now available as a pre-print 🩸🧪🧠 medrxiv.org/content/10.1101/… @andrealessa @M_SuarezCalvet @Alamarbio @jmschott @BarbaraBorroni7 @alessandro5161 @goteborgsuni @BarcelonaBeta
11
2
28
2,193